Clinical Trial Update: Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso [Phase 4]

View source ↗

Summary

A Phase 4 trial in Burkina Faso completed assessing the efficacy of two ACT regimens, Amodiaquine-Artesunate and Artemether-Lumefantrine, for malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Amodiaquine + Artesunate
• Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: Centre Muraz | Conditions: Malaria | Phase 4 | Status: COMPLETED